✦ LIBER ✦

P.2.047 5HT2A and DRD4 molecular genotypes in a clinical trial of olanzapine versus risperidone in schizophrenic patients

✍ Scribed by H. Nicolini; C. Cruz; B. Camarena; H. Ortega

Book ID: 118599970
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 139 KB
Volume: 7
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(97)88682-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.114 Association of 5-HT2A receptor p

P.3.114 Association of 5-HT2A receptor polymorphisms with clinical outcome of risperidone in schizophrenic patients

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 121 KB

P.3.d.009 Olanzapine versus risperidone:

P.3.d.009 Olanzapine versus risperidone: weight gain and BMI of schizophrenic patients in a 24-week trial

✍ Siladji-Mladenovic, D.; Knezevic, V.; Ivezic, A.; Drezgic-Vukic, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB

P.3.a.036 Association between polymorphi

P.3.a.036 Association between polymorphisms of the 5HT2A receptor gene and positive symptom response to olanzapine treatment in patients with schizophrenia

✍ L. Olajossy-Hilkesberger; B. Godlewska; M. Olajossy; H. Marmurowska-Michalowska 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 63 KB

PMH31 Cost-Effectiveness of Long-Acting

PMH31 Cost-Effectiveness of Long-Acting Olanzapine Versus Long-Acting Risperidone in Patients with Schizophrenia in Spain

✍ T. Dilla; P. O'Donohoe; J. Möller; M. Álvarez; J. Sacristán; L. San; M. Happich; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

P.247 Prediction of treatment outcome in

P.247 Prediction of treatment outcome in genotype 4 chronic hepatitis C patients during combined pegylated interferon alpha-2a and ribavirin therapy (ANRS 1211 trial)

✍ G. Esmat; H. ElMakhzangy; S. Males; R.R. Gad; C. Rekacewicz; S.A. Ismail; M. Abd 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Effects of warm-supplementing kidney yan

Effects of warm-supplementing kidney yang (WSKY) capsule added on risperidone on cognition in chronic schizophrenic patients: a randomized, double-blind, placebo-controlled, multi-center clinical trial

✍ Zhen-hua Chen; Gao-hua Wang; Xiao-ping Wang; Ren-yun Chen; Hui-lin Wang; Ming-hu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Abstract ## Objective To evaluate the effects of warm‐supplementing kidney yang (WSKY) capsule added on risperidone on cognition in chronic schizophrenic patients. ## Methods A randomized, double‐blind, placebo‐controlled, multi‐center clinical trial was conducted. All 200 patients who met th